Peptidi li jimbuttaw ir-riċerka 'l quddiem.
L-għażla tar-riċerkaturi.
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%
DEAL −15%Lookbook.
Erba' dipartimenti.
Kull kompost, dokumentat.
Qatt kunjett bla isem.
Kull prodott jintbagħat bil-karta Peptheon tiegħu — l-identità, il-forma u l-klassi tal-kompost b'ħarsa waħda, flimkien ma' testijiet tal-laboratorju, dokumentazzjoni tal-lott u konsenja diskreta u traċċabbli bħala standard.
Mill-iskrivanija tar-riċerka.
BioregulatorsCartalax and Chonluten: the bioregulators with almost no published record
Same Khavinson school as Thymalin and Epithalon, a fraction of the evidence. One cell-culture study for Chonluten, no readable efficacy study at all for Cartalax — and that asymmetry is the article.
LongevityEpithalon and the telomere claim: what the Khavinson papers actually report
Telomerase reactivation in a dish, extra passages past the Hayflick limit, longer-lived flies and mice — and no modern human trial. The published Epithalon record, figure by figure.
PerformanceMyostatin inhibitors: ACE-083 went to phase 2, follistatin-344 never left the lab
One follistatin-based molecule grew muscle in two randomised phase 2 trials and still failed where it mattered. The other has only animal data, a black market, and a retinal case series. The published record, side by side.